Strategic Partnership Between Genedata and IDBS Aims to Further Streamline Biopharma Discovery, Development and Manufacturing

ZEISS Announces Collaborative Research Partnership with Max Planck Florida Institute for Neuroscience

The press release announces ZEISS has formed a research collaboration partnership with the Max Planck Florida Institute for Neuroscience (MPFI).

‘UK government can deliver Brexit benefit with world’s best medicines security’ say FarmaTrust

Company forewarns the UK is risking fake COVID-19 vaccines and other medicines without a new system

Samsung Biologics Shares ‘Vision’ for Next Decade at the 39th Annual JP Morgan Healthcare Conference

Jumpcode Genomics Secures $21M in Series B Funding

The RSA Group welcomes Eleanor Davies as Managing Partner

The RSA Group, a leading Life Sciences Executive Search firm, is delighted to announce the appointment of a new senior team member. Eleanor Davies joins the company as Managing Partner.

Global healthtech company Raremark appoints Nicki Grundy as its Chief Financial Officer

Raremark, the global healthtech company specialising in rare disease, has appointed Nicki Grundy as Chief Financial Officer to support the accelerated levels of growth the company is experiencing.

Antibiotic Research UK announces the appointment of Mr. Simon Dukes as Chair Designate of the Board of Trustees

Antibiotic Research UK is delighted to announce the appointment of Mr. Simon Dukes as Chair Designate of its Board of Trustees.

Optibrium Enhances Compound Design Strategies in Major Upgrade to StarDrop Software

• New features include reaction-based library enumeration for novel molecule generation and optimisation • AI-integrated with seamless interface to Optibrium’s Artificial Intelligence platform, Cerella, to extract greater value from drug discovery data

European Medicines Agency Selects Panalgo for Real-World Data Analytics

The EMA will use Panalgo’s Instant Health Data (IHD) platform to rapidly answer questions around drug safety and efficacy and better understand real-world medication use.

BOC Sciences comprehensively deploys liposomal drug delivery research to seek industry-wide cooperation

Panthera began dosing volunteers in AstraZeneca’s phase III of its long-acting antibody combination AZD7442 for the prevention of COVID-19 at its sites in Preston, North Manchester and North London

Panthera’s clinical trial sites are helping to evaluate an alternative AstraZeneca vaccine for people who are unable to have the currently approved Covid-19 vaccines. The treatment is aimed at helping those people with a compromised immune system, who cannot be vaccinated, vaccine hesitant and those who are unlikely to respond to a vaccination.

Enveda Biosciences Systematically Harnesses Untapped Potential of Nature’s Chemistry to Develop Next-Gen Therapeutics

ComputaBio Has Launched Molecular Dynamics Simulation Services for Drug R&D Projects

ComputaBio, a US supplier of professional computational biology services, has launched molecular dynamics simulation services for industrial and academic customers to expedite the process of drug design.

Octapharma Selects Model N Revenue Cloud for Life Sciences

BOC RNA and Dr. Shiyue Fang Announced Plans to Cooperate Closely in Sensitive DNA/RNA Synthesis

Alfa Chemistry Supplies Varieties of Dyes for Industrial Use

AMZELL to initiate FDA-approved Phase 3 trial of innovative injectable treatment for infantile epileptic disease

Specialist development pharmaceutical company AMZELL B.V has concluded discussions with the FDA ahead of initiating a Phase 3 trial of its new treatment for infantile epileptic disease, AMZ002.

Matexcel Provides a Wide Selection of Antimicrobial Material Products

Real-time logistics monitoring from Roambee proven to address COVID-19 vaccine distribution challenges

Roambee’s technology solution for real-time logistics visibility has been proven to overcome many of the challenges of global COVID-19 vaccine distribution.